ScholarIQanswers from OpenAlex & ORCID
Laurence Moore
ResearcherPublications, citations & collaboration network
Laurence Moore is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Laurence Moore have?
ScholarIQindexed works
Laurence Moore has 394 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Laurence Moore have?
ScholarIQcitation count
Laurence Moore has 32,598 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Laurence Moore?
ScholarIQh-index
Laurence Moore has an h-index of 64 in OpenAlex.
What is the i10-index of Laurence Moore?
ScholarIQi10-index
Laurence Moore has an i10-index of 180 in OpenAlex.
What is the ORCID of Laurence Moore?
ScholarIQorcid
The ORCID for Laurence Moore is on the source record.
What is the OpenAlex record for Laurence Moore?
ScholarIQopenalex
The OpenAlex for Laurence Moore is on the source record.
What are the most-cited papers on Laurence Moore?
ScholarIQmost cited works
Process evaluation of complex interventions: Medical Research Council guidance
Gary F. Moore, Suzanne Audrey, Mary Barker, Lyndal Bond, Chris Bonell, Wendy Hardeman, Laurence Moore, Alicia O’Cathain, Tannaze Tinati, Daniel Wight, Janis Baird
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Kathryn Skivington, Lynsay Matthews, Sharon Simpson, Peter Craig, Janis Baird, Jane Blazeby, Kathleen Boyd, Neil Craig, David French, Emma McIntosh, Mark Petticrew, Jo Rycroft‐Malone, Martin White, Laurence Moore
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice Dutcher, Robert A. Figlin, Anil Kapoor, Elżbieta Starosławska, Jeffrey A. Sosman, David McDermott, I. Bodrogi, Zoran Kovačević, Vladimir Lesovoy, Ingo G.H. Schmidt‐Wolf, О. Л. Барбараш, Erhan Gökmen, Timothy E. O’Toole, Stephanie Lustgarten, Laurence Moore, Robert J. Motzer
The need for a complex systems model of evidence for public health
Harry Rutter, Natalie Savona, Ketevan Glonti, Jo Bibby, Steven Cummins, Diane T. Finegood, Felix Greaves, Laura Harper, Penelope Hawe, Laurence Moore, Mark Petticrew, Eva Rehfuess, Alan Shiell, James Thomas, Martin White
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Heß, Raoul Herbrecht, Jorge Romaguera, Gregor Verhoef, Michael Crump, Christian Gisselbrecht, Anna Laurell, Fritz Offner, Andrew Strahs, Anna Berkenblit, Orysia Hanushevsky, Jill S. Clancy, Becker Hewes, Laurence Moore, Bertrand Coiffier